FDA records linked by MedtechLedger identify Pro3Dure Medical GmbH as the applicant behind THERMEO® I MSI, a prescription mouthguard device assigned product code MQC and reviewed under a traditional 510(k) pathway. The clearance letter dated September 29, 2026 lists the trade name Thermeo® I MSI, an unclassified regulatory class and product code MQC, with the submission dated and received August 14, 2026. The same applicant name appears on an earlier Thermeo System clearance, K212017, dated April 8, 2022, also under product code MQC. Company background comes from the manufacturer's own published pages, which describe a medical technology company founded in 2013 and based in Iserlohn, Germany. [1][2][8][7]
Documented FDA filings
The linked filing sample contains one 510(k) record: THERMEO® I MSI, K260031, decided September 29, 2026 with decision code SESE, meaning substantially equivalent. The record lists product code MQC, device name Mouthguard, Prescription, a traditional clearance type, no third-party review, and a summary statement. The applicant address in the record is Am Burgberg 13, Iserlohn, Germany. [1]
The clearance letter for K260031 is addressed to Pro3dure Medical GmbH care of regulatory specialist Patricia Kontoudis of Kontoudis Consulting, LLC in Baltimore, Maryland. It names the trade device as Thermeo® I MSI, regulatory class unclassified, product code MQC, and records the submission as dated and received August 14, 2026. [2]
An earlier FDA letter, K212017 dated April 8, 2022, names the same applicant and the trade device Thermeo System, again unclassified and under product code MQC. That letter is addressed to Frank Gischer as technical director at the Iserlohn address. These two letters are the dated submission examples available in the numbered sources. [8]
Product and technology scope
The K260031 review documentation describes CAD/CAM milling technology systems and lists product state as blank, with performance testing to ISO 20795-2 and biocompatibility testing to ISO 10993. The manufacturer's instructions for THERMEO® MSI describe a milling blank with a thermomemory effect, intended only for CAD/CAM fabrication of occlusal orthodontic splints and stated as compatible with common CAD/CAM systems, with tungsten carbide instruments specified for machining. [2][3]
The manufacturer's dental brochure places THERMEO® within a product family and lists an ISM-1 | MSI mouthguard entry alongside printodent resins carrying MSI technology. A product page for THERMEO® states that amine compounds and MMA were avoided during development to reduce yellowing and potential for irritation and sensitization, and that cleaning recommendations were tested. These are manufacturer statements about material composition and handling, not clinical findings. [5][6]
Company identity and published positioning
The manufacturer's company page states that pro3dure medical was founded in 2013 and is headquartered in Iserlohn, in North Rhine-Westphalia, and describes 3D as the central focus of its activities across audiology, dental and medical technology. The corporate site describes the company as serving customers in 3D printing across audiology, dental, medical and research sectors and cites over 10 years of expertise. [7][4]
A brochure lists a USA contact, pro3dure medical LLC, at Valley View Business Center in Eden Prairie, Minnesota, alongside the Iserlohn phone and email contact. That listing documents a US contact entity; it does not establish ownership, parentage or corporate structure, which remain unknown from the numbered sources. FDA filing addresses are correspondence addresses and are not treated here as headquarters. [9][7]
What the record does not establish
The linked collection is an as-of snapshot of the filings provided: one 510(k) record, with a decision count of one SESE and a sample decision count of one SESE. These figures describe the collected records only and are not measures of total company sales, total portfolio size or safety performance. No recall records appear in the sample. [1]
The numbered sources do not document customers, certifications beyond the standards named in review documentation, commercial availability in specific markets, or independent testing results. Claims about biofilm effects appear in manufacturer material framed as reducing undesirable biofilm formation without microbicidal effect; they are reported as manufacturer statements rather than verified outcomes. [3][9]

